AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Enough new-generation anthrax vaccine to dose 25 million people: That's first on the U.S. government's shopping list under a massive new program to develop and stockpile antidotes to biological and chemical weapons.
Called Project BioShield, the $5.6 billion program passed the House on a 414-2 vote. The Senate passed it in May and President George W. Bush's signature is guaranteed.
Federal health officials have their wish list ready: antidotes for botulism and anthrax, a safer smallpox vaccine, and a long-awaited children's version of an anti-radiation pill.
"The passage of Project Bioshield is a watershed in our mission to defend America against bioterrorism, establishing a first line of defense against biological weapons," said Representative Christopher Cox, chairman of the House Homeland Security Committee.
Bush said in a statement that he looked forward to signing the bill, which would help protect the homeland and "break new ground in the search for treatments and cures while strengthening our overall biotechnology infrastructure."
Project BioShield doesn't mean the government will make these products. Instead, it offers pharmaceutical companies a guaranteed buyer, an incentive the industry has long sought before spending millions in research to produce terrorism countermeasures. ...